StockWatch
·
Pharmaceuticals
Clarification25 Sept 2026, 02:06 pm

Caplin Point Clarifies Volume Surge: Market Driven

AI Summary

Caplin Point Laboratories Ltd has responded to BSE's query regarding a significant increase in its equity share trading volume. The company stated that it has made all requisite disclosures as per SEBI LODR Regulations and has not withheld any material or price-sensitive information. Caplin Point confirmed that the surge in trading volume is purely market-driven and they are not aware of any specific reasons contributing to it. The company reiterated its commitment to complying with all applicable disclosure requirements.

Key Highlights

  • Company clarifies significant increase in trading volume.
  • No material or price-sensitive information withheld.
  • Volume surge attributed to market-driven factors.
  • Company confirms compliance with SEBI disclosure norms.